Position in SLS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$23,910,134
+$18,512,723 QoQ
Shares Held
1,619,928
+27.0% QoQ
Ownership
0.802%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 192 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in SLS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. SLS ranks #68 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in SLS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,910,134 | 1,619,928 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $5,397,411 | 1,275,984 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,508,926 | 930,750 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,177,191 | 731,175 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,529,699 | 698,493 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $177,541 | 164,390 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $140,109 | 134,721 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $126,053 | 100,843 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $120,002 | 100,843 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $89,616 | 88,730 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $66,183 | 62,437 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $64,550 | 39,360 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $61,795 | 39,360 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $42,925 | 30,018 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $88,903 | 37,671 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $76,095 | 37,671 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $54,869 | 24,605 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $165,797 | 24,820 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $136,065 | 24,605 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $225,381 | 24,605 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $273,115 | 24,605 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $154,659 | 18,110 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $94,307 | 16,232 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||